Professional Documents
Culture Documents
UNGROUPED RADIOPHARMACEUTICALS
CHEMICAL NAME HALF LIFE IMAGING DIAGNOSTIC USE
Gallium-67 3.26 days PLANAR Demonstrate the presence/extent of:
GalliumCitrate Hodgkin’s disease
Lymphoma
Bronchogenic carcinoma
Aid in detecting some acute inflammatory lesions
Mo-99 generator 2.7489 days Mo/Tc Generation of Tc-99m sodium pertechnetate for administration or radiopharmaceutical preparation.
generators
Nitrogen-13 Ammonia 9.97 min PET Imaging:
Myocardium
Pharmacologic stress conditions to evaluate myocardial perfusion
Suspected/existing coronary artery disease
Radium-223 dichloride 11.4 days Treatment:
Castration-resistant prostate cancer
Symptomatic bone metastases
Unknown visceral metastatic disease
Rubidium-82chloride 1.27 minutes PET Myocardial perfusion agent
Distinguishing normal from abnormal myocardium
Suspected myocardial infarction
Samarium-153EDTMP 46.3 hours Pain reliever for confirmed osteoblastic metastatic bone lesions
Strontium-89 chloride 50 days Bone pain reliever for skeletal metastases that have been confirmed prior to therapy
Thallium-201 chloride 72.912 hrs SPECT/PLANAR Imaging: Myocardial perfusion
Localization: myocardial infarction
Supplemental diagnosis: ischemic heart disease (atherosclerotic coronary artery disease)
Localization of sites: parathyroid hyperactivity w/elevated serum calcium and parathyroid hormone levels.
Xenon-133gas 5.2475 days PLANAR Evaluation of pulmonary function, imaging for lungs & Assessment of cerebral flow
IODINE RADIOPHARMACEUTICALS GROUP
CHEMICAL CHEMICAL NAME HALF LIFE IMAGING DIAGNOSTIC USE
SYMBOL
Iodine-123 Lobenguane 13.22 SPECT Detection of primary/metastatic pheochromocytoma or neuroblastoma
123I hours Imaging: Neuroendocrine tumor
Iodine – 123 Ioflupane Brain Imaging: Striatal dopamine transporter visualization
Evaluation of Suspected Parkinsonian Syndrome: differentiate essential tremor e.g. (idiopathic Parkinson’s disease,
multiple system atrophy and progressive supranuclear palsy)
Iodine– 123 Sodium iodide Evaluation of thyroid, Function and Morphology
125I Iodine– 125 Human serum 59.4 days Determining Total blood Plasma volume
albumin
Iodine– 125 Iothalamate Evaluation of glomerular filtration
Iodine – 131Human serum Used in determining:
131I albumin 8.0197 Total blood and plasma volumes
days Cardiac output
Cardiac and pulmonary blood volume and circulation time
Protein turnover studies
Heart and great vessel delineation
Localization of the placenta
Localization of cerebral neoplasm
Iodine – 131 Sodium iodide SPECT Radioactive iodide(RAI) test: Evaluate thyroid function
Localizing metastases associated with thyroid malignancies
Treatment for :
Hyperthyroidism
Carcinoma of the thyroid
Iodine – 131 Tositumomab Treatment for:
CD20antigen-expressing relapsed or refractory,
Low grade ,follicular, or transformed non-Hodgkin’s lymphoma
Rituximab-refractory non-Hodgkin’s lymphoma
Iodine– 131Iodohippurate To determine renal function, effective renal plasma flow, urinary tract obstruction
sodium
TECHNETIUM-99M RADIOPHARMACEUTICALS GROUP
CHEMICAL CHEMICAL NAME HALF IMAGING DIAGNOSTIC USE
SYMBOL LIFE
Technetium-99m bicisate SPECT Localization of Stroke
Technetium-99m disofenin Diagnosis of Acute Cholecystitis
Technetium-99m exametazine Detection of altered regional perfusion in stroke
Leukocyte labelled scintigraphy for inflammatory bowel disease
Technetium-99m macroaggregated albumin PLANAR Evaluation of pulmonary perfusion & peritovenous shunt patency(artery)
Technetium-99m mebrofenin Imaging agent for hepatobiliary
Technetium-99m medronate PLANAR Bone imaging agent for delineation of altered osteogenesis
Technetium-99m oxidronate
99m
Tc Technetium-99m mertiatide 6.0058 Imaging agent for:
Hrs Renal Failure
Urinary Obsturction
Calculi
Renal Function